Ameriprise’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Ameriprise’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,418	Closed	-$325K	–	4046
2021 Q1	$325K	Buy	+5,418	New	+$196K	﹤0.01%	3567

Ameriprise's PAND Position: Q2 2021 in Review

Ameriprise sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 5,418 shares — an estimated $325K sold.

Ameriprise first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $325K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Ameriprise reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ameriprise sold 5,418 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $325K.
Ameriprise first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Ameriprise's Pandion Therapeutics Inc. Common Stock position peaked at $325K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.